KWALITY PHARMACEUTICALS LTD.

NSE : NABSE : 539997ISIN CODE : INE552U01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE494.4523.5 (+4.99 %)
PREV CLOSE ( ) 470.95
OPEN PRICE ( ) 494.45
BID PRICE (QTY) 494.45 (6669)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5519
TODAY'S LOW / HIGH ( )493.55 494.45
52 WK LOW / HIGH ( ) 248545
NSE
This Company is not listed in NSE
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax255.721615.67212.72109.17109.10
Adjustment209.51135.6090.9470.8752.20
Changes In working Capital10.14-731.7727.24-91.298.89
Cash Flow after changes in Working Capital475.381019.51330.8988.75170.19
Cash Flow from Operating Activities413.82605.97267.0561.65135.76
Cash Flow from Investing Activities-484.41-629.28-232.03-177.98-117.83
Cash Flow from Financing Activities9.9456.577.67117.72-20.01
Net Cash Inflow / Outflow-60.6533.2642.701.38-2.09
Opening Cash & Cash Equivalents91.3558.0915.3814.0016.09
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent30.7091.3558.0915.3814.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.